November 2, 2017
Sanofi Q3 sales up, business net income $2,141
Sanofi’s Q3 2017 sales performance were supported by Sanofi Genzyme, Sanofi Pasteur and Emerging Markets, and it saw net sales…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 2, 2017
Pfizer launches antifungal drug Cresemba in Spain, Basilea looks at $427 million
Basilea Pharmaceutica said Thursday its licensing partner Pfizer recently launched the antifungal drug Cresemba (isavuconazole) in Spain. Pfizer is now commercializing…
November 2, 2017
Tigenix protects its Chron’s disease treatment
TiGenix has further strengthened its IP protection around the company’s lead product Cx601, intended for the treatment of complex perianal fistulas…
November 1, 2017
Pharmapack Europe 2018 to showcase evolution and revolution in packaging and drug delivery
Pharmapack Europe 2018 today announced the comprehensive event programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition…
October 31, 2017
Actelion to be delisted from SIX Swiss Exchange in November
Actelion said on Tuesday that, by decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all…
October 31, 2017
Novartis waits second indication Kymriah to reach more patients
Novartis said on Tuesday that it has submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug…
October 30, 2017
Mereo BioPharma agrees with AstraZeneca for exclusive license and option to acquire AZD9668
Mereo BioPharma has made a deal with AstraZeneca for an exclusive license, including an option to acquire, AZD9668, an oral inhibitor…
October 30, 2017
Hemogenyx selects LakePharma as its service provider for making CDX bi-specific antibodies
Hemogenyx Pharmaceuticals has picked LakePharma as its service provider for the development and manufacturing of Hemogenyx’s lead product, CDX bi-specific…
October 30, 2017
Novartis expands its oncology arm with AAA
Novartis said on Monday that it wants to buy Advanced Accelerator Applications (AAA), a radiopharmaceutical company that owns and sells…
October 27, 2017
Sandoz is seeking approval for use of its biosimilar to Amgen’s Neulasta, EMA to take a look at it
Novartis division Sandoz has gotten acceptance for its biosimilar to Amgen’s Neulasta by the European Medicines Agency (EMA) for regulatory…